Contact
Please use this form to send email to PR contact of this press release:
Global Blood Therapeutics Announces GBT440 Granted Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease
TO:
Please use this form to send email to PR contact of this press release:
Global Blood Therapeutics Announces GBT440 Granted Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease
TO: